![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Beattie R.M.
Publisher: Adis International
ISSN: 1174-5878
Source: Pediatric Drugs, Vol.2, Iss.3, 2000-05, pp. : 193-203
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapy of Crohn’s disease in childhood
By Beattie R Mark Bremner A Ronald F
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Certolizumab pegol effective maintenance therapy for Crohn's disease
Inpharma, Vol. 1, Iss. 1598, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab maintenance therapy valuable strategy in Crohn's disease.
Inpharma, Vol. 1, Iss. 1313, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: a biological breakthrough in Crohn's disease therapy
Inpharma, Vol. 1, Iss. 1247, 2000-01 ,pp. :